Achieve Life Sciences, Inc. (ACHV)
NCM – Real Time Price. Currency in USD
6.02
+0.32 (5.61%)
At close: Jun 26, 2026, 4:00 PM EDT
5.94
-0.08 (-1.33%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
6.02
+0.32 (5.61%)
At close: Jun 26, 2026, 4:00 PM EDT
5.94
-0.08 (-1.33%)
After-hours: Jun 26, 2026, 7:56 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $28.1M significantly exceed its total debt $15.0M, ensuring strong financial flexibility
Total current assets $31.1M exceed Total current liabilities $11.8M, highlighting excellent liquidity
Debt-to-equity ratio (1.4) is near the industry average, reflecting balanced leverage
Interest coverage ratio (-38.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$6.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.62 | 6.05 | 10 | |
| Quick ratio | 2.62 | 5.63 | 10 | |
| Debt to Equity | 1.40 | 0.30 | 5.0 | |
| Debt to Assets | 0.45 | 1.04 | 5.0 | |
| Interest coverage | -38.19 | -16.91 | 1.0 | |
| Weighted average score | 6.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -236K | -228K | -229K | -228K | -223K |
| Operating Income | -41M | -27M | -39M | -55M | -52M |
| Net Income | -42M | -30M | -40M | -55M | -52M |
| EBITDA | -41M | -27M | -39M | -55M | -52M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 57.54 | 5.5 |
| Next quarter | N/A | 40.24 | 5.5 |
| Current year | N/A | 42.82 | 5.5 |
| Next year | N/A | 35.48 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 30.65 | 32.14 | 61.45 | 10 |
| Y/Y | 999 | 20.73 | 48.65 | 37.48 | 10 |
| 3y average | 999 | -13.71 | 26.34 | -17.61 | 5.5 |
| 5y average | 999 | -38.78 | 21.14 | -39.73 | 5.5 |
| Weighted average score | 7.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |